Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Triclabendazole Treatment Failure forFasciola hepaticaInfection among Preschool and School-Age Children, Cusco, Peru1

Emerging infectious diseases(2021)10.3201/eid2707.203900Source: DataRank Database

Triclabendazole Treatment Failure forFasciola hepaticaInfection among Preschool and School-Age Children, Cusco, Peru1 is a research paper published in Emerging infectious diseases (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.89)OA: goldTopics (67)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Melinda B. Tanabe ORCID,A. Clinton White ORCID,Martha López ORCID,Ruben Bascope,Miguel M. Cabada ORCID

Live enrichment

PubMed:34152949 PMC:PMC8237897 OpenAlex:https://openalex.org/W3173548735

NIAID NIH HHS

Grant: R01 AI104820

National Institutes of Health

Grant: 1R01AI104820-01

Impact of Fascioliasis among Children in the Peruvian Highlands

National Institutes of Health

Grant: 5R01AI104820-04

Impact of Fascioliasis among Children in the Peruvian Highlands

FWCI

3.89

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://wwwnc.cdc.gov/eid/article/27/7/pdfs/20-3900.pdf

publisherhttps://wwwnc.cdc.gov/eid/article/27/7/pdfs/20-3900.pdf

journalhttps://doi.org/10.3201/eid2707.203900

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34152949

repositoryhttps://doaj.org/article/c2befb7139c6493b875973951e187f2e

Fields of Study

Helminth infection and controlParasites and Host InteractionsParasite Biology and Host Interactions03 medical and health sciences0302 clinical medicineAdolescentAnimalsAnthelminticsChildChild, PreschoolFasciola hepaticaFascioliasisFecesFemaleHumansPeruRetrospective StudiesSchoolsTreatment FailureTriclabendazole

MeSH Terms

TriclabendazoleAdolescentAnimalsAnthelminticsChildChild, PreschoolFasciola hepaticaFascioliasisFecesFemaleHumansPeruRetrospective StudiesSchoolsTreatment Failure

Keywords

TriclabendazoleFasciola hepaticaFasciolaCohortInternal medicineMedicineBiologyHelminthsImmunologyInfectionDrug resistancePreschool childrenAntimicrobial resistanceSchool-age childrenparasitesefficacyPeruFascioliasisLiver FlukeTreatment FailureTrematodeCuscoAnthelminticsSchoolsAdolescentFecesChild, PreschoolAnimalsHumansFemaleChildRetrospective Studies

Sustainable Development Goals

SDG 0: Good health and well-being